Trials / Unknown
UnknownNCT01584726
Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma
Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation: A Randomized, Double-Blind, Controlled Trial (RCT)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Hamad Medical Corporation · Industry
- Sex
- All
- Age
- 2 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the use of magnesium sulfate nebulization in patient with moderate to severe asthma exacerbation in pediatric emergency.
Detailed description
the use of magnesium sulfate nebulization in patient with moderate to severe asthma exacerbation in pediatric emergency follow asthma severity score and length of stay
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Magnesium Sulfate | single dose of magnesium sulfate nebulization |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2015-03-01
- Completion
- 2015-12-01
- First posted
- 2012-04-25
- Last updated
- 2014-01-28
Locations
2 sites across 1 country: Qatar
Source: ClinicalTrials.gov record NCT01584726. Inclusion in this directory is not an endorsement.